ABVC BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.42 USD | -10.69% |
|
+43.42% | +22.41% |
Chart calendar ABVC BioPharma, Inc.
79e663c791447c3b24dbd346f3ad8e7._tzUmwF1O26i5JF-UgM3cD_ZrlWpZwIlxP-qi65Ahg4.kLi2rW88TCHskOAhHW58J1vv_SL6HU4Xs7L7psR5x2qItbboOCZLN8mc3A~1772cd58fe5d8f4f4d4411123d2713ca
Upcoming events on ABVC BioPharma, Inc.
Past events on ABVC BioPharma, Inc.
| 2024-03-14 09:30 am | Q4 2023 Earnings Release |
| 2024-01-16 08:00 am | Annual General Meeting |
| 2023-11-15 09:00 am | Q3 2023 Earnings Release |
| 2023-03-31 06:49 pm | Q4 2022 Earnings Release |
| 2022-11-14 06:20 pm | Q3 2022 Earnings Release |
| 2022-08-15 05:48 pm | Interim 2022 Earnings Release |
| 2022-05-20 09:00 am | Annual General Meeting |
| 2022-05-16 05:46 pm | Q1 2022 Earnings Release |
| 2022-03-31 04:18 pm | FY 2021 Earnings Release |
| 2022-03-29 11:00 am | Maxim Group Virtual Growth Conference - Panel |
| 2021-11-15 04:33 pm | Q3 2021 Earnings Release |
| 2021-08-12 08:27 am | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,70 | 0,48 0,54 -10.14% | 0,36 0,59 -39.58% | 0,97 0,39 146.06% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,51 -4,96 -71.6% | -11,7 -6,92 -69.11% | -15,1 -17,0 10.89% | 0,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,8 -7,95 -35.94% | -11,2 -6,98 -60.72% | -15,5 -16,9 8.12% | -13,1 |
|
Net income Million USD | Released Forecast Spread | -3,64 | -9,79 -6,81 -43.85% | -12,8 -5,99 -114.23% | -16,4 -16,5 0.48% | 0,00 |
|
EPS USD | Released Forecast Spread | -2,10 | -5,00 -3,40 -47.06% | -5,10 -2,30 -121.74% | -5,20 -5,20 0% | 0,00 |
| Announcement Date | 15/05/20 | 16/03/21 | 31/03/22 | 31/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | -0,04 0,20 -120.48% | 0,31 0,03 1107.02% | 0,04 0,03 61.46% | 0,59 0,01 4355.3% | 0,13 0,00 - | |
|
EBIT Million USD | Released Forecast Spread | -6,45 -1,66 -287.62% | -2,05 -3,95 48.24% | -3,72 -6,34 41.43% | -3,13 -4,98 37.11% | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,89 -1,65 -255.95% | -2,03 -3,93 48.38% | -3,77 -6,30 40.11% | -3,54 -4,96 28.65% | ||
|
Net income Million USD | Released Forecast Spread | -7,93 -1,09 -630.05% | -6,00 | -1,86 -3,84 51.61% | -3,70 -6,12 39.42% | -4,86 -4,87 0.05% | |
|
EPS USD | Released Forecast Spread | -3,10 -0,40 -675% | -2,00 | -0,60 -1,25 52% | -1,10 -2,00 45% | -1,50 -1,50 0% | -0,60 -0,50 -20% |
| Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 |
More events
Past sector events for ABVC BioPharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABVC Stock
- Calendar ABVC BioPharma, Inc.
